Assessment of the clinical features of rheumatoid arthritis-related interstitial lung diseases: a retrospective evaluation

被引:1
|
作者
Genc, A. C. [1 ]
Ozturk, Z. [2 ]
Kara, A. B. [3 ]
Genc, F. Turkoglu [1 ]
Aydemir, Y. [4 ]
Gunduz, Y. [3 ]
Gonullu, E. [2 ]
机构
[1] Sakarya Univ, Dept Internal Med, Fac Med, Sakarya, Turkiye
[2] Sakarya Univ, Dept Rheumatol, Fac Med, Sakarya, Turkiye
[3] Sakarya Univ, Dept Radiol, Fac Med, Sakarya, Turkiye
[4] Sakarya Univ, Dept Pulmonol, Fac Med, Sakarya, Turkiye
关键词
Rheumatoid arthritis; Interstitial lung disease; Carbon monoxide diffusion capacity; Spirometric function tests; INVOLVEMENT; MORTALITY; PROVEN; COHORT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Rheumatoid Arthritis (RA) stands as the most prevalent form of inflammatory arthritis, affecting approximately 1% of the population. Among individuals diagnosed with RA, a notable proportion, ranging from 10% to 40%, also experience Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD). This coexistence of RA and ILD has been identified as a detrimental factor contributing to increased mortality rates. Furthermore, RA-ILD often exhibits an insidious nature, posing challenges in its timely detection and management. Hence, our objective was to conduct a retrospective analysis of the clinical characteristics observed in patients who underwent evaluation for RA-ILD. PATIENTS AND METHODS: A total of 87 patients who were evaluated for RA- ILD within one year were included in the study. This study was conducted retrospectively using a cross-sectional and descriptive approach to analyze the demographic and clinical data of the included patients. RESULTS: Among the 87 patients, eight were diagnosed with RA-ILD, with four being male and four being female. Of the eight patients, two had non- specific interstitial pneumonia, five had usual interstitial pneumonia, and one had nodules consistent with RA. Subpleural fibrosis increased the likelihood of RA-ILD by 6.9 times. In the group with ILD, the residual volume and total capacity were found to be lower compared to the other group. Among the eight patients diagnosed with RA-ILD, five had used methotrexate before the diagnosis. CONCLUSIONS: In order to mitigate the risk of delayed diagnosis of RA-ILD, which can lead to increased mortality and has a subtle onset, it is recommended that patients with RA who possess certain risk factors undergo regular monitoring. It is advisable for RA patients to undergo annual assessments involving carbon monoxide diffusion capacity and spirometry function tests. In cases, where deemed necessary, more advanced investigations such as high-resolution computed tomography should be conducted.
引用
收藏
页码:8486 / 8493
页数:8
相关论文
共 50 条
  • [21] PULSED CYCLOPHOSPHAMIDE IN THE TREATMENT OF RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE (RA-ILD)
    Kelly, C.
    Palmer, E.
    Gordon, J.
    Woodhead, F.
    Nisar, M.
    Arthanari, S.
    Forbes-Price, A.
    Middleton, D.
    Dempsey, O.
    Dawson, J.
    Sathi, N.
    Ahmad, Y.
    Koduri, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 74 - 74
  • [22] Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
    Reyes, Felipe
    Saavedra, Silvana
    Vergara, Karen
    Florenzano, Matias
    Wolff, Veronica
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [23] RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE
    Eroglu, Didem Sahin
    Colaklar, Anil
    Baysal, Serdar
    Torgutalp, Murat
    Baygul, Asaf
    Yayla, Mucteba Enes
    Sezer, Serdar
    Uzun, Caglar
    Kumbasar, Ozlem Ozdemir
    Turgay, Tahsin Murat
    Kinikli, Gulay
    Ates, Askin
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2022, 39 (03)
  • [24] Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    ARCHIVES OF RHEUMATOLOGY, 2023,
  • [25] Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (02) : 317 - 329
  • [26] Ultrasound Evaluation of Interstitial Lung Disease in Rheumatoid Arthritis and Autoimmune Diseases
    Vicente-Rabaneda, Esther F.
    Bong, David A.
    Busquets-Perez, Noemi
    Moller, Ingrid
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2024, 11
  • [27] Clinical features of rheumatoid arthritis-associated interstitial lung disease
    Wang, Ting
    Zheng, Xing-Ju
    Liang, Bin-Miao
    Liang, Zong-An
    SCIENTIFIC REPORTS, 2015, 5
  • [28] Clinical features of rheumatoid arthritis-associated interstitial lung disease
    Ting Wang
    Xing-Ju Zheng
    Bin-Miao Liang
    Zong-An Liang
    Scientific Reports, 5
  • [29] Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease
    Narvaez, Javier
    Robles-Perez, Alejandro
    Molina-Molina, Maria
    Vicens-Zygmunt, Vanesa
    Luburich, Patricio
    Anibal Yanez, Marcos
    Jose Alegre, Juan
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 902 - 910
  • [30] Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease
    Ito, Yuhei
    Arita, Machiko
    Kumagai, Shogo
    Takei, Reoto
    Noyama, Maki
    Tokioka, Fumiaki
    Nishimura, Keisuke
    Koyama, Takashi
    Tachibana, Hiromasa
    Ishida, Tadashi
    MODERN RHEUMATOLOGY, 2019, 29 (01) : 98 - 104